This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Movement Disorder Quantification Algorithm Development

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Great Lakes NeuroTechnologies Inc.
ClinicalTrials.gov Identifier:
NCT01534650
First received: February 14, 2012
Last updated: February 22, 2017
Last verified: February 2017
  Purpose
The purpose of this study is to collect kinematic motion data from subjects with movement disorders such as Parkinson's disease (PD) and essential tremor (ET) to develop and validate algorithms for quantifying motor symptoms such as tremor, bradykinesia (slowed movements), dyskinesias (sudden, involuntary movements), gait, and balance during standardized tasks and/or activities of daily living.

Condition
Parkinson's Disease Essential Tremor

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Great Lakes NeuroTechnologies Inc.:

Primary Outcome Measures:
  • Processed kinematics [ Time Frame: During assessment ]
    Motion data collected during various motor tasks will be processed and compared to video review.


Enrollment: 17
Study Start Date: February 2012
Study Completion Date: January 2016
Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Residents of Northeastern Ohio with a movement disorder such as Parkinson's disease or essential tremor.
Criteria

Inclusion Criteria:

  • Aged 18 years or older
  • Clinical diagnosis of idiopathic Parkinson's disease or essential tremor
  • Able to provide informed consent

Exclusion Criteria:

  • Significant medical or psychiatric illness
  • Not capable of following the required clinical instructions
  • Serious medical conditions that compromise safety
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01534650

Locations
United States, Ohio
Great Lakes NeuroTechnologies Inc. Movement Disorders Laboratory
Valley View, Ohio, United States, 44125
Sponsors and Collaborators
Great Lakes NeuroTechnologies Inc.
Investigators
Principal Investigator: Dustin A Heldman, PhD Great Lakes NeuroTechnologies Inc.
  More Information

Responsible Party: Great Lakes NeuroTechnologies Inc.
ClinicalTrials.gov Identifier: NCT01534650     History of Changes
Other Study ID Numbers: GLNT-001
Study First Received: February 14, 2012
Last Updated: February 22, 2017

Keywords provided by Great Lakes NeuroTechnologies Inc.:
motion sensors
tremor
bradykinesia
gait
balance
dyskinesia

Additional relevant MeSH terms:
Parkinson Disease
Tremor
Essential Tremor
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Movement Disorders
Neurodegenerative Diseases
Dyskinesias
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on August 21, 2017